Thrombophilia Treatment Market size was over USD 16.74 billion in 2023 and is anticipated to reach USD 39.37 billion by 2036, growing at around 6.8% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of thrombophilia treatment is estimated at USD 17.65 billion. The growth of the market can be attributed to the growing burden of obesity, and increasing prevalence of cardiovascular and trauma cases across the world. According to the World Health Organization, as of now, cardiovascular diseases account for about 17.9 million deaths, which is an estimated 32 percent of all the deaths globally.
Along with these, rise in consumption of alcohol and tobacco is predicted to add a risk of development of high blood pressure on veins leading to several thrombophilia complications, which in turn is expected to fuel the market growth in the upcoming years. Furthermore, escalating research and development spending in the field of hematological diseases, and government initiatives to raise awareness regarding blood disorders are projected to offer profitable opportunities to the market in the near future.
Growth Drivers
Challenges
|
Base Year |
2023 |
|
Forecast Year |
2024-2036 |
|
CAGR |
6.8% |
|
Base Year Market Size (2023) |
USD 16.74 billion |
|
Forecast Year Market Size (2036) |
USD 39.37 billion |
|
Regional Scope |
|
The market is segmented by end user into hospitals, homecare, specialty centers, and others, out of which, the hospitals segment is anticipated to hold the largest share in the global thrombophilia treatment market. This can be accounted to the high preference of patients to get their treatment by a healthcare professional operating in a hospital facility, and increase in the number of hospital admissions. Additionally, on the basis of type, the factor V Leiden segment is evaluated to acquire the largest share during the forecast period, which can be credited to the commonness of this type of thrombophilia among the general population. Apart from this, the upsurge in the number of people with genetic mutations around the globe is also assessed to drive growth to the market segment in the imminent time.
Our in-depth analysis of the global thrombophilia treatment market includes the following segments:
|
By Type |
|
|
By Drugs |
|
|
By End User
|
|
APAC Market Statistics
On the basis of geographical analysis, the global thrombophilia treatment market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and the Middle East & Africa region. Asia Pacific industry is set to account for largest revenue share by 2036, owing to growing investments for improving healthcare infrastructure, and larger patient pool in the region.
North America Market Analysis
Moreover, the market in North America is expected to occupy the largest share during the forecast period ascribing to the rising demand for progressive treatment options, and early adoption of technologies, especially in the United States. In addition, increasing geriatric population, and growing collaboration of domestic and international companies for awareness campaigns are also predicted to boost the region’s market growth in the coming years. As per the data given by Rural Health Information Hub, there are more than 46 million adults aged 65 years or older living in the United States as of 2019. By 2050, this number is anticipated to reach almost 90 million.
July 2021- Sanofi highlighted new research from first-in-class investigational therapies in hemophilia, immune thrombocytopenia and acquired thrombotic thrombocytopenic purpura.
September 2020- Aspen Global Incorporated announced that it has divested its wholly owned subsidiary incorporated in Mauritius with Mylan Ireland Limited. The latter will acquire all the intellectual property related to Aspen’s Thrombosis Business in Europe1.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?